Tirzepatide

Research Grade GLP-1 Synthetic Derivative

Overview: Tirzepatide is a cutting-edge synthetic derivative of the Glucagon-Like Peptide-1 (GLP-1), designed specifically for the scientific community to advance research in metabolic disorders and diabetes management. With its unique structure and mode of action, Tirz represents a promising frontier for investigating new therapeutic strategies.

Product Specifications:

• Purity: >99% (HPLC verified)
• Formulation: Lyophilized powder for reconstitution
• Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
• Molecular Weight: 4813.524 g/mol
• CAS Number: 2023788-19-2
• PubChem CID: 156588324

Source: PubChem

Research Applications:

Tirz is extensively utilized in preclinical studies to explore its potential in:

• Enhancing insulin secretion
• Regulating blood sugar levels
• Investigating weight management pathways
• Exploring cardiovascular benefits

Features:

• Synthetic GLP-1 Derivative: Engineered for high specificity and stability, making it an ideal candidate for in-depth biological studies.
• Versatile Research Tool: Suitable for various experimental setups including in vitro assays, animal models, and pharmacokinetic/pharmacodynamic evaluations.
• Quality Controlled: Each batch undergoes rigorous quality testing to ensure the highest purity and consistency for reliable research outcomes.

Important Notice: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

COA Batch 2023-0624-5HHT (5mg)

Batch 2023-0624-5HHT